#BREAKING: WHO Approves Sinopharm Vaccine For Emergency Use

WHO today listed the Sinopharm COVID-19 vaccine for emergency use, giving the green light for this vaccine to be rolled out globally. The Sinopharm vaccine is produced by Beijing Bio-Institute of Biological Products Co Ltd, subsidiary of China National Biotec Group (CNBG). WHO Communication “The addition of this vaccine has the potential to rapidly accelerate COVID-19 vaccine access for countries seeking to protect health workers and populations at risk,” said Dr Mariângela Simão, WHO Assistant-Director General for Access to Health Products. We urge the manufacturer to participate in the COVAX…

Read More

WHO Zimbabwe Expert Clarifies On Sinopharm Vaccine, Says Sinopharm And More Other Vaccines Awaiting WHO Emergency Use Approval

There is nothing unusual about Sinopharm being administered before getting the WHO SAGE approval Only Four Vaccines have received the WHO EUL approval SAGE likely to make recommendations to Sinopharm end of March or beginning of April THE Sinopharm, Sinovac, Suptnik and at least 30 more other vaccines have submitted their dossiers to the World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) for them to be listed for emergency use amidst indications that to date, only four vaccines namely the Pfizer Biotech, Astrazeneca, Mordena and Johnson & Johnson…

Read More